Verition Fund Management LLC Global Blood Therapeutics, Inc. Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $2.6 Million - $5.46 Million	80,094 New	80,094 $5.45 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $1.05 Million - $1.69 Million	-41,989 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $1.07 Million - $1.57 Million	41,989 New	41,989 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $160,765 - $272,297	-4,270 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $53,129 - $75,011	1,007 Added 30.86%	4,270 $235,000
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $159,005 - $266,978	3,263 New	3,263 $206,000
Q2 2018 Aug 15, 2018	SELL	$38.7 - $50.15 $168,383 - $218,202	-4,351 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$39.6 - $65.9 $172,299 - $286,730	4,351 New	4,351 $210,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.